Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-06-12
2007-06-12
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S113000
Reexamination Certificate
active
10865454
ABSTRACT:
The present invention discloses and claims compounds of formula Iand their pharmaceutically acceptable salts, and methods of using said compounds of formula I, either alone or in combination with other medicaments, as antiarrhythmic medicaments with a cardioprotective component for prophylaxis or treatment of infarction, for the treatment of angina pectoris, and as inhibitors of pathophysiological processes associated with the development of ischemia-induced damage, in particular in the triggering of ischemia-induced cardiac arrhythmias and of heart failure. Pharmaceutical compositions comprising compounds of formula I or compounds of formula I in combination with one or more other medicaments and processes for the preparation of compounds of formula I are also disclosed and claimed.
REFERENCES:
patent: 19622222 (1997-12-01), None
patent: 0 622 356 (1994-11-01), None
patent: 0 708 091 (1996-04-01), None
patent: 0 708 091 (1996-04-01), None
patent: 0 708 091 (1996-07-01), None
patent: 0 972 767 (2000-01-01), None
patent: WO 2004/007479 (2004-01-01), None
U.S. Appl. No. 10/749,630 and U.S. Appl. No. 10/749,631.
Akito, T. Novel Guanidine Derivative, Patent Abstracts of Japan, vol. 1998, No. 2, Jan. 30, 1998 and JP 09 278767 (Fujisawa Pharmaceut. Co. Ltd.)(Oct. 28, 1997).
Boivin, G. P. et al, Variant Form of Diffuse Corporal Gastritis in NHE2 Knockout Mice, Comparative Medicine, vol. 50, Issue 5(2000) pp. 511-515.
Masereel B et al, An overview of inhibitors of Na+/H exchanger, European Journal of Medicinal Chemistry, vol. 38, No. 6(Jun. 2003) pp. 547-554.
Schultheis P. J. et al, Targeted Disruption of the Murine Na+/H+ Exchanger Isoform 2 Gene Causes Reduced Viability of Gastric Parietal Cells and Loss of Net Acid Secretion, J. Clin. Invest., vol. 101, Issue 6, (1998)pp. 1243-1253.
Carry Jean-Christophe
Desmazeau Pascal
Doerflinger Gilles
Evers Michel
Genevois-Borella Arielle
Chung Susannah L.
Lin Jiang
Martin Lawrence L.
Saeed Kamal A.
Sanofi-Aventis Deutschland GmbH
LandOfFree
Derivatives of 3-(Guanidinocarbonyl) heterocycle, methods of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Derivatives of 3-(Guanidinocarbonyl) heterocycle, methods of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Derivatives of 3-(Guanidinocarbonyl) heterocycle, methods of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3854832